Avatrombopag

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 227 publications

Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report

Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: April 14, 2026

Thrombopoietin Receptor Agonist (Avatrombopag) Preoperative Administration to Ameliorate Sepsis-Related Thrombocytopenia in Jehovah's Witness Patients Undergoing Redo Cardiac Surgery for Acute Endocarditis: A Case Report.

Thrombopoietin Receptor Agonist (Avatrombopag) Preoperative Administration to Ameliorate Sepsis-Related Thrombocytopenia in Jehovah's Witness Patients Undergoing Redo Cardiac Surgery for Acute Endocarditis: A Case Report.

Journal: A&A practice
Published: April 10, 2026

Single-cell transcriptome deciphers key targets of thrombopoietin receptor agonists and immune microenvironment characteristics of immune thrombocytopenia.

Single-cell transcriptome deciphers key targets of thrombopoietin receptor agonists and immune microenvironment characteristics of immune thrombocytopenia.

Journal: Platelets
Published: April 01, 2026

Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.

Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.

Journal: Expert opinion on pharmacotherapy
Published: March 24, 2026

Avatrombopag and Platelet Recovery in Sepsis-Associated Thrombocytopenia: A Retrospective Observational Cohort Study.

Avatrombopag and Platelet Recovery in Sepsis-Associated Thrombocytopenia: A Retrospective Observational Cohort Study.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 13, 2026

Refractory Primary Immune Thrombocytopenia With Bleeding and Thrombosis: A Case Report.

Refractory Primary Immune Thrombocytopenia With Bleeding and Thrombosis: A Case Report.

Journal: The American journal of case reports
Published: February 15, 2026

Predicting Avatrombopag response in children with immune thrombocytopenia: A multi-view learning framework for tabular missing data.

Predicting Avatrombopag response in children with immune thrombocytopenia: A multi-view learning framework for tabular missing data.

Journal: Computer methods and programs in biomedicine
Published: February 01, 2026

Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study.

Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study.

Journal: Annals of hematology
Published: February 01, 2026

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

Journal: British journal of haematology
Published: January 23, 2026

Real-World Safety and Efficacy of Avatrombopag in Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.

Real-World Safety and Efficacy of Avatrombopag in Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.

Journal: European journal of haematology
Published: January 15, 2026

Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.

Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.

Journal: Journal of clinical medicine
Published: January 12, 2026

Integrated Assessment of Three NDSRIs Through CPCA Prioritization, In Silico Toxicity Assessment, and Stability Indicating LC-MS/MS Method for Avatrombopag Maleate.

Integrated Assessment of Three NDSRIs Through CPCA Prioritization, In Silico Toxicity Assessment, and Stability Indicating LC-MS/MS Method for Avatrombopag Maleate.

Journal: Biomedical chromatography : BMC
Published: January 09, 2026
Showing 1-12 of 227

Last Updated: 06/30/2026